Kedi Flam Tablet is a combination analgesic and anti-inflammatory medication containing Aceclofenac (100mg), Paracetamol (325mg), and Serratiopeptidase (15mg). Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), effectively reduces inflammation and pain by inhibiting cyclooxygenase enzymes involved in prostaglandin synthesis. Paracetamol provides analgesic and antipyretic effects by acting centrally to elevate the pain threshold and reduce fever without significant anti-inflammatory activity. Serratiopeptidase, a proteolytic enzyme, facilitates the breakdown of inflammatory mediators and promotes the resolution of edema and swelling, enhancing tissue healing. This combination is indicated for the management of acute and chronic musculoskeletal pain, including osteoarthritis, rheumatoid arthritis, postoperative pain, dental pain, and soft tissue injuries. Kedi Flam Tablet offers rapid and sustained relief from pain and inflammation while improving functional mobility. It should be used under medical supervision, especially in patients with gastrointestinal disorders, hepatic or renal impairment, or hypersensitivity to NSAIDs. Common adverse effects may include gastrointestinal discomfort, nausea, or allergic reactions. Caution is advised when co-administered with other NSAIDs, anticoagulants, or corticosteroids. Overall, Kedi Flam Tablet provides an effective therapeutic option for multimodal pain management and inflammation control.